During the past decade, Gastroenterology Associates of Central Georgia, LLC conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 30 clinical trials were completed, i.e. on average, 85.7% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 20 clinical trials were completed. i.e. 166.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Gastroenterology Associates of Central Georgia, LLC" #1 sponsor was "Hoffmann-La Roche" with 6 trials, followed by "Janssen Research & Development, LLC" with 6 trials sponsored, "Pfizer" with 6 trials sponsored, "Celgene" with 5 trials sponsored and "Bausch Health Americas, Inc." with 5 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gastroenterology Associates of Central Georgia, LLC" #1 collaborator was "Gilead Sciences" with 3 trials as a collaborator, "Galapagos NV" with 1 trials as a collaborator, "National Center for Complementary and Integrative Health (NCCIH)" with 1 trials as a collaborator, "Syneos Health" with 1 trials as a collaborator and "Takeda Development Center Americas, Inc." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Gastroenterology Associates of Central Georgia, LLC" are "Ulcerative Colitis" (14 trials), "Crohn's Disease" (13 trials), "Crohn Disease" (7 trials), "Colitis, Ulcerative" (5 trials) and "Eosinophilic Esophagitis (EoE)" (3 trials). Many other conditions were trialed in "Gastroenterology Associates of Central Georgia, LLC" in a lesser frequency.

Most popular intervention types in "Gastroenterology Associates of Central Georgia, LLC" are "Drug" (52 trials), "Other" (8 trials), "Biological" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (29 trials), "CP-690,550" (5 trials), "Etrolizumab" (4 trials), "Filgotinib" (4 trials) and "Guselkumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Gastroenterology Associates of Central Georgia, LLC" are 53 trials for "All" genders.

Currently, there are NaN active trials in "Gastroenterology Associates of Central Georgia, LLC". undefined are not yet recruiting, 9 are recruiting, 7 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 29 completed trials in Gastroenterology Associates of Central Georgia, LLC, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Gastroenterology Associates of Central Georgia, LLC, 1 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 42 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".